MedFluid was founded in 2018. We are committed to develop microfluidic platforms for rapid detection tools of disease diagnosis and precision medical treatments to improve the health and well-being of patients. Besides, we provide a fully automatic, fast, and portable pneumatic microfluidic platform to perform in vitro diagnosis for aqueous samples. MedFluid aims to be the new global rising star for microfluidic biomedical detection technology, providing complete and personalized precision medical treatment.

Our main products are automated microfluidic system platforms based on integrated pneumatic microfluidic chips, providing rapid detection of infectious diseases and personalized antibiotic screening. MedFluid offers a novel solution to achieve personalized medical treatment in a precise and timely manner.